SecBot SecBot
144 ·Filed May 22, 2026

ANAB

ANAPTYSBIO, INC
BEARISH
Impact 5/10
Horizondays Processed5mo ago SEC0001950047-26-004947
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

This is the fourth insider sale filing from the same officer within one week, signaling a routine option-exercise/cash-out cycle but at an elevated frequency. For a $1.5B biotech with no disclosed near-term catalyst, the concentrated selling is a modest negative signal. Monitor for additional Form 4 filings or a material change in corporate outlook that could explain the selling.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$57.77
T+0 close · May 22, 2026 · via day close
Latest settled
+2.58%
T+60 · $59.26
Vs SPY
−0.15%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 26 $57.77entry
  2. T+1 · 6mo ago −0.14%α −0.15% · $57.69
  3. T+5 · 6mo ago −11.27%α −12.48% · $51.26
  4. T+20 · 5mo ago +1.92%α +3.87% · $58.88
  5. T+60 · 3mo ago +2.58%α −0.15% · $59.26
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dennis Mulroy, an officer of AnaptysBio, filed a Form 144 notice of intent to sell 10,000 shares of common stock, valued at approximately $593,008 based on the filing date price. This follows three prior sales in the same week totaling 35,467 shares for ~$2.16M, indicating a concentrated selling pattern by an insider.

Key Facts

  • Form 144 filed on 2026-05-22 by officer Dennis Mulroy
  • Proposed sale of 10,000 shares of common stock
  • Estimated value: ~$593,008 at market price on filing date
  • Shares acquired via stock option exercise on 05/22/2026 for cash
  • Three prior open-market sales by Mulroy in the preceding week: 15,467 shares on 05/21 ($928k), 10,000 on 05/19 ($599k), 10,000 on 05/15 ($633k)
  • Cumulative insider sales by Mulroy in the past week: ~45,467 shares for ~$2.75M

Financial Impact

Proposed additional sale of ~$593k; combined week of insider selling totals ~$2.75M against a $1.5B market cap

dilutioninsider ownership

Risk Factors

  • Insider selling may indicate lack of confidence in near-term share appreciation
  • Biotech sector volatility could amplify any negative sentiment from insider sales

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-004947
Document: 0001950047-26-004947-index.html0001950047-26-004947
Document: 0001950047-26-004947.txt0001950047-26-004947

Track record

28 reports on ANAB

Performance horizon

9 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 12 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 5, 2026